Mechanisms of bile acid–induced (BA-induced) liver injury in cholestasis are controversial,
limiting development of new therapies. We examined how BAs initiate liver injury using …

Biliary atresia (BA) is characterized by periductular inflammation and fibrosis and is
associated with the progressive obliteration of the bile ducts. The induction and …

Biliary atresia (BA) is a congenital cholestatic disease that can seriously damage children's
liver function. It is one of the main reasons for liver transplantation in children. Early …

Biliary atresia (BA) is a progressive fibroinflammatory obstruction of extrahepatic bile ducts
that presents as neonatal cholestasis. Due to the overlap in clinical, biochemical, and …

Background & Aims The pathogenesis of intestinal failure (IF) associated liver disease
(IFALD) is uncertain, we therefore investigated the role of FGF19 and pro-inflammatory …

Biliary atresia (BA) is a severe chronic cholestasis disorder of infants that leads to death if
not treated on time. Neonatal hepatitis syndrome (NHS) is another leading cause of …

Abstract Background and Aim Biliary atresia (BA) is a progressive fibro‐inflammatory
cholangiopathy with an unclear etiology. Various liver disorders are associated with an …

Biliary atresia (BA) is a severe cholestatic liver disease in children featuring cholestasis and
liver fibrosis. The early diagnosis of BA is still challenging. This study aimed to evaluate the …

Objective: The lack of reliable noninvasive diagnostic biomarkers of biliary atresia (BA)
results in delayed diagnosis and worsened patient outcome. Circulating microRNAs …

Objectives: A connection between the bowel and bile ducts after the Kasai
hepatoportoenterostomy (HPE) procedure poses a risk of ascending cholangitis. There were …